Dr. Jason Porter details groundbreaking research for NSCLC

Posted by & filed under Uncategorized.

Dr. Jason Porter details groundbreaking research for KRAS-mutant NSCLC during a Targeted Oncology Community Case Forum. 🎉 Explore the CodeBreaK 100 and CodeBreaK 200 studies, showing promising results and insights into new treatment strategies. Read more about the accelerated approval of new treatment options, and their impact on patients’ lives. Let’s revolutionize #LungCancer care together!… Read more »

Lung Cancer

Posted by & filed under Uncategorized.

Our lung cancer team is recognized by the community as exceptional from prevention and diagnosis to the latest treatments. Lung cancer is one of the most common types of cancer, but the good news is the growing number of new therapies. At West Cancer Center & Research Institute, our specialists can provide you with new... Read more »

New Lung Screening Program

Posted by & filed under Uncategorized.

Our West Family is excited to launch a lung screening program at several of our campuses across the MidSouth! Patients and referring providers can schedule an appointment to receive a low-dose CT scan to detect lung cancer early. We accept all major insurance carriers and patients must meet the following criteria: – Between the ages of… Read more »

David Portnoy, MD, FACP Previews Immunotherapy Breakthroughs – Shaking Up Frontline SCLC Paradigm

Posted by & filed under Uncategorized.

Click here to view this full article on OncLive.com.    The addition of immune checkpoint inhibitors to chemotherapy has led to durable responses and improved survival without increased toxicity in patients with small cell lung cancer (SCLC), according to David C. Portnoy, MD, FACP, who added that biomarkers of response to this approach and a… Read more »